Quick Takeaways
- This page summarizes Axel Bolte's Form 4 filing for Inozyme Pharma, Inc. (INZY).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 20 Apr 2022, 16:05.
Axel Bolte - 19 Apr 2022 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)
- Signature
- /s/ Axel Bolte
- Issuer symbol
- INZY
- Transactions as of
- 19 Apr 2022
- Net transactions value
- +$249,998
- Form type
- 4
- Filing time
- 20 Apr 2022, 16:05:37 UTC
- Previous filing
- 28 Feb 2022
- Next filing
- 13 May 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"Axel Bolte filed Form 4 for Inozyme Pharma, Inc. (INZY) on 20 Apr 2022."
What Changed
- Previous filing in this sequence was filed on 28 Feb 2022.
- Current net transaction value: +$249,998.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
INZY
transaction
Common Stock
Purchase
- Transaction value
- $249,998
- Shares
- +67,750
- Change %
- +36%
- Price
- $3.69
- Shares after
- 258,575
- Date
- 19 Apr 2022
- Ownership
- Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.